Literature DB >> 34160529

Just add water: hydratable, morphologically diverse nanocarrier powders for targeted delivery.

Sharan Bobbala1, Michael P Vincent1, Evan A Scott2.   

Abstract

Two major obstacles that limit the widespread usage of polymeric nanocarriers include the complexity of formulation methods and their stability during storage. To address both of these issues, here we present morphologically complex nanocarriers in a hydratable powder form, which bypasses the need for expensive, harsh, and/or time-consuming nanocarrier fabrication techniques. The powders are composed of carbohydrates and self-assembling polymer amphiphiles having a low glass transition temperature. Hydration requires less than one minute and only involves the addition of aqueous media (water or saline) to rapidly obtain self-assembled micelles, worm-like micelles (i.e. filomicelles), or polymersomes from poly(ethylene glycol)-b-poly(propylene sulfide) (PEG-b-PPS) polymers. The formulated powders are highly stable, achieving hydration into monodisperse nanocarriers following >6 months of storage. Diverse drug cargoes were efficiently encapsulated during hydration, including hydrophobic small molecules for micellar morphologies, as well as individual and concurrent loading of both hydrophobic and hydrophilic molecules for vesicular morphologies. Hydrated polymersomes are shown to load hydrophilic biological macromolecules, and encapsulated enzymes retain bioactivity. Furthermore, we demonstrate that inclusion of lipid-anchored ligands in powder form permits the surface-display of targeting ligands and enhances target cell uptake, thereby extending this technology to targeted drug delivery applications. Our powder-based formulation strategy was extendable to commercially available polymer amphiphiles, including PEG-b-polystyrene and PEG-b-polycaprolactone. The formulated nanotechnologies described herein are highly modular, require minimal preparation, and remain stable in ambient long-term storage (bypassing cold chain requirements), which will enable their use in medicine (human and veterinary), research, and commercial applications from cosmetics to agriculture.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34160529      PMCID: PMC8343964          DOI: 10.1039/d1nr02188e

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   8.307


  47 in total

Review 1.  The mechanism of the alkaline phosphatase reaction: insights from NMR, crystallography and site-specific mutagenesis.

Authors:  K M Holtz; E R Kantrowitz
Journal:  FEBS Lett       Date:  1999-11-26       Impact factor: 4.124

Review 2.  Proliposomes for oral delivery: progress and challenges.

Authors:  Vijaykumar Nekkanti; Natarajan Venkatesan; Guru V Betageri
Journal:  Curr Pharm Biotechnol       Date:  2015       Impact factor: 2.837

Review 3.  Monoclonal antibodies: formulations of marketed products and recent advances in novel delivery system.

Authors:  Yanan Cui; Ping Cui; Binlong Chen; Suxin Li; Hua Guan
Journal:  Drug Dev Ind Pharm       Date:  2017-01-22       Impact factor: 3.225

4.  Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule.

Authors:  M D Pierschbacher; E Ruoslahti
Journal:  Nature       Date:  1984 May 3-9       Impact factor: 49.962

5.  Solution stability of linear vs. cyclic RGD peptides.

Authors:  S J Bogdanowich-Knipp; S Chakrabarti; T D Williams; R K Dillman; T J Siahaan
Journal:  J Pept Res       Date:  1999-05

6.  Formulation, evaluation, and pharmacokinetics of isradipine proliposomes for oral delivery.

Authors:  Sharan Kumar Reddy Bobbala; Prabhakar Reddy Veerareddy
Journal:  J Liposome Res       Date:  2012-07-04       Impact factor: 3.648

7.  Aggregation behavior of poly(ethylene glycol-bl-propylene sulfide) di- and triblock copolymers in aqueous solution.

Authors:  Simona Cerritelli; Conlin P O'Neil; Diana Velluto; Antonella Fontana; Marc Adrian; Jacques Dubochet; Jeffrey A Hubbell
Journal:  Langmuir       Date:  2009-10-06       Impact factor: 3.882

8.  Inhibition of apical but not basolateral endocytosis of ricin and folate in Caco-2 cells by cytochalasin D.

Authors:  M R Jackman; W Shurety; J A Ellis; J P Luzio
Journal:  J Cell Sci       Date:  1994-09       Impact factor: 5.285

9.  An Injectable Hydrogel Platform for Sustained Delivery of Anti-inflammatory Nanocarriers and Induction of Regulatory T Cells in Atherosclerosis.

Authors:  Sijia Yi; Nicholas B Karabin; Jennifer Zhu; Sharan Bobbala; Huijue Lyu; Sophia Li; Yugang Liu; Molly Frey; Michael Vincent; Evan A Scott
Journal:  Front Bioeng Biotechnol       Date:  2020-06-05

10.  Surface chemistry-mediated modulation of adsorbed albumin folding state specifies nanocarrier clearance by distinct macrophage subsets.

Authors:  Michael P Vincent; Sharan Bobbala; Nicholas B Karabin; Molly Frey; Yugang Liu; Justin O Navidzadeh; Trevor Stack; Evan A Scott
Journal:  Nat Commun       Date:  2021-01-28       Impact factor: 17.694

View more
  3 in total

Review 1.  Leveraging self-assembled nanobiomaterials for improved cancer immunotherapy.

Authors:  Michael P Vincent; Justin O Navidzadeh; Sharan Bobbala; Evan A Scott
Journal:  Cancer Cell       Date:  2022-02-10       Impact factor: 31.743

2.  Dendritic peptide-conjugated polymeric nanovectors for non-toxic delivery of plasmid DNA and enhanced non-viral transfection of immune cells.

Authors:  Sijia Yi; Sun-Young Kim; Michael P Vincent; Simseok A Yuk; Sharan Bobbala; Fanfan Du; Evan Alexander Scott
Journal:  iScience       Date:  2022-06-08

3.  Surface Engineering of FLT4-Targeted Nanocarriers Enhances Cell-Softening Glaucoma Therapy.

Authors:  Michael P Vincent; Trevor Stack; Amir Vahabikashi; Guorong Li; Kristin M Perkumas; Ruiyi Ren; Haiyan Gong; W Daniel Stamer; Mark Johnson; Evan A Scott
Journal:  ACS Appl Mater Interfaces       Date:  2021-07-07       Impact factor: 10.383

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.